Prevention and treatment of venous thromboembolism during HRT: current perspectives

References

• FilesJAKoMGPruthiSBioidentical hormone therapyMayo Clin Proc201186767368021531972
   PubMed Web of Science ®Google Scholar
• ConawayEBioidentical hormones: an evidence-based review for primary care providersJ Am Osteopath Assoc2011111315316421464264
   PubMedGoogle Scholar
• MoskowitzDA comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risksAltern Med Rev200611320822317217322
   PubMedGoogle Scholar
• HoltorfKThe bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?Postgrad Med20091211738519179815
   PubMed Web of Science ®Google Scholar
• XuXRomanJMIssaqHJKeeferLKVeenstraTDZieglerRGQuantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometryAnal Chem200779207813782117848096
   PubMed Web of Science ®Google Scholar
• RossouwJEAndersonGLPrenticeRLWriting Group for the Women’s Health Initiative InvestigatorsRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
   PubMed Web of Science ®Google Scholar
• AndersonGLLimacherMAssafARWomen’s Health Initiative Steering CommitteeEffects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trialJAMA2004291141701171215082697
   PubMed Web of Science ®Google Scholar
• VickersMRMacLennanAHLawtonBWISDOM groupMain morbidities recorded in the women’s international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal womenBMJ2007335761323917626056
   PubMed Web of Science ®Google Scholar
• HulleySGradyDBushTRandomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research GroupJAMA199828076056139718051
   PubMed Web of Science ®Google Scholar
• CanonicoMOgerEPlu-BureauGEstrogen and Thromboembolism Risk (ESTHER) Study GroupHormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER studyCirculation2007115784084517309934
   PubMed Web of Science ®Google Scholar
• SmithNLHeckbertSRLemaitreRNEsterified estrogens and conjugated equine estrogens and the risk of venous thrombosisJAMA2004292131581158715467060
   PubMed Web of Science ®Google Scholar
• CushmanMKullerLHPrenticeRWomen’s Health Initiative InvestigatorsEstrogen plus progestin and risk of venous thrombosisJAMA2004292131573158015467059
   PubMed Web of Science ®Google Scholar
• Pérez GutthannSGarcía RodríguezLACastellsagueJDuque OliartAHormone replacement therapy and risk of venous thromboembolism: population based case-control studyBMJ199731470837968009081000
   PubMed Web of Science ®Google Scholar
• HøibraatenEQvigstadEArnesenHLarsenSWickstrømESandsetPMIncreased risk of recurrent venous thromboembolism during hormone replacement therapy – results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)Thromb Haemost200084696196711154141
   PubMed Web of Science ®Google Scholar
• CanonicoMFournierACarcaillonLPostmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort studyArterioscler Thromb Vasc Biol201030234034519834106
   PubMed Web of Science ®Google Scholar
• EischerLEichingerSKyrlePAThe risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort studyJ Thromb Haemost201412563564024548536
   PubMed Web of Science ®Google Scholar
• BathPMGrayLJAssociation between hormone replacement therapy and subsequent stroke: a meta-analysisBMJ2005330748734215640250
   PubMed Web of Science ®Google Scholar
• FormosoGPerroneEMaltoniSShort and long term effects of tibolone in postmenopausal womenCochrane Database Syst Rev20122CD00853622336846
   PubMed Web of Science ®Google Scholar
• MansonJEHsiaJJohnsonKCWomen’s Health Initiative InvestigatorsEstrogen plus progestin and the risk of coronary heart diseaseN Engl J Med2003349652353412904517
   PubMed Web of Science ®Google Scholar
• CherryNGilmourKHannafordPESPRIT teamOestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trialLancet200236093502001200812504395
   PubMed Web of Science ®Google Scholar
• RossouwJEPrenticeRLMansonJEPostmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopauseJAMA2007297131465147717405972
   PubMed Web of Science ®Google Scholar
• SchierbeckLLRejnmarkLToftengCLEffect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trialBMJ2012345e640923048011
   PubMed Web of Science ®Google Scholar
• HaysJOckeneJKBrunnerRLWomen’s Health Initiative InvestigatorsEffects of estrogen plus progestin on health-related quality of lifeN Engl J Med2003348191839185412642637
   PubMed Web of Science ®Google Scholar
• LidegaardØNielsenLHSkovlundCWSkjeldestadFELøkkegaardERisk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001–2009BMJ2011343d642322027398
   PubMed Web of Science ®Google Scholar
• KohKKShinMSSakumaIEffects of conventional or lower doses of hormone replacement therapy in postmenopausal womenArterioscler Thromb Vasc Biol20042481516152115166013
   PubMed Web of Science ®Google Scholar
• HolmegardHNNordestgaardBGSchnohrPTybjaerg-HansenABennMEndogenous sex hormones and risk of venous thromboembolism in women and menJ Thromb Haemost201412329730524329981
   PubMed Web of Science ®Google Scholar
• van StaaTPSprafkaJMStudy of adverse outcomes in women using testosterone therapyMaturitas2009621768019108962
   PubMed Web of Science ®Google Scholar
• BlondonMvan Hylckama VliegAWigginsKLDifferential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkersJ Thromb Haemost201412687988624628832
   PubMed Web of Science ®Google Scholar
• van BaalWMEmeisJJvan der MoorenMJKesselHKenemansPStehouwerCDImpaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomised, placebo-controlled 12-week studyThromb Haemost2000831293410669150
   PubMed Web of Science ®Google Scholar
• PostMSChristellaMThomassenLGEffect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal womenArterioscler Thromb Vasc Biol20032361116112112730085
   PubMed Web of Science ®Google Scholar
• ScarabinPYAlhenc-GelasMPlu-BureauGTaisnePAgherRAiachMEffects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women: a randomized controlled trialArterioscler Thromb Vasc Biol19971711307130789409295
   PubMed Web of Science ®Google Scholar
• TeedeHJMcGrathBPSmolichJJPostmenopausal hormone replacement therapy increases coagulation activity and fibrinolysisArterioscler Thromb Vasc Biol20002051404140910807761
   PubMed Web of Science ®Google Scholar
• OgerEAlhenc-GelasMLacutKSARAH InvestigatorsDifferential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trialArterioscler Thromb Vasc Biol20032391671167612869355
   PubMed Web of Science ®Google Scholar
• BagotCNMarshMSWhiteheadMThe effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapyJ Thromb Haemost2010881736174420553380
   PubMed Web of Science ®Google Scholar
• [No authors listed]Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI TrialJAMA199527331992087807658
   PubMed Web of Science ®Google Scholar
• SomaMROsnago-GaddaIPaolettiRThe lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal womenArch Intern Med199315312146214688390232
   PubMedGoogle Scholar
• ScarabinPYOgerEPlu-BureauGEStrogen and THromboEmbolism Risk Study GroupDifferential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism riskLancet2003362938242843212927428
   PubMed Web of Science ®Google Scholar
• RoachRELijferingWMHelmerhorstFMCannegieterSCRosendaalFRvan Hylckama VliegAThe risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapyJ Thromb Haemost201311112413123136837
   PubMed Web of Science ®Google Scholar
• RenouxCDell’AnielloSSuissaSHormone replacement therapy and the risk of venous thromboembolism: a population-based studyJ Thromb Haemost20108597998620230416
   PubMed Web of Science ®Google Scholar
• LalibertéFDeaKDuhMSKahlerKHRolliMLefebvrePDoes the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapyMenopause201118101052105921775912
   PubMed Web of Science ®Google Scholar
• HemelaarMRosingJKenemansPThomassenMCBraatDDvan der MoorenMJLess effect of intranasal than oral hormone therapy on factors associated with venous thrombosis risk in healthy postmenopausal womenArterioscler Thromb Vasc Biol20062671660166616645152
   PubMed Web of Science ®Google Scholar
• GuimarãesDAdos SantosMSGomesKBInteraction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal womenMenopause201219333934522089178
   PubMed Web of Science ®Google Scholar
• BergendalABremmeKHedenmalmKRisk factors for venous thromboembolism in pre-and postmenopausal womenThromb Res2012130459660122704078
   PubMed Web of Science ®Google Scholar
• SuminoHIchikawaSSawadaYEffects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal womenThromb Res2005115535936615733968
   PubMed Web of Science ®Google Scholar
• LoweGWoodwardMVesseyMRumleyAGoughPDalyEThrombotic variables and risk of idiopathic venous thromboembolism in women aged 45–64 years. Relationships to hormone replacement therapyThromb Haemost200083453053510780311
   PubMed Web of Science ®Google Scholar
• HerringtonDMVittinghoffEHowardTDFactor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary diseaseArterioscler Thromb Vasc Biol20022261012101712067913
   PubMed Web of Science ®Google Scholar
• WuORobertsonLLanghornePOral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) StudyThromb Haemost2005941172516113779
   PubMed Web of Science ®Google Scholar
• StraczekCOgerEYon de Jonage-CanonicoMBEstrogen and Thromboembolism Risk (ESTHER) Study GroupProthrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administrationCirculation2005112223495350016301339
   PubMed Web of Science ®Google Scholar
• SodeBFAllinKHDahlMGyntelbergFNordestgaardBGRisk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood typeCMAJ20131855E229E23723382263
   PubMed Web of Science ®Google Scholar
• PsatyBMSmithNLLemaitreRNHormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal womenJAMA2001285790691311180734
   PubMed Web of Science ®Google Scholar
• HershALStefanickMLStaffordRSNational use of postmenopausal hormone therapy: annual trends and response to recent evidenceJAMA20042911475314709575
   PubMed Web of Science ®Google Scholar
• StephensonKNeuenschwanderPFKurdowskaAKThe effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal womenInt J Pharm Compd2013171748523627249
   PubMedGoogle Scholar
• RosanoGMWebbCMChierchiaSNatural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal womenJ Am Coll Cardiol20003672154215911127455
   PubMed Web of Science ®Google Scholar
• HillebrandUHausbergMStockC17beta-estradiol increases volume, apical surface and elasticity of human endothelium mediated by Na+/H+ exchangeCardiovasc Res200669491692416412402
   PubMed Web of Science ®Google Scholar
• SmithNLBlondonMWigginsKLLower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogensJAMA Intern Med20141741253124081194
   PubMed Web of Science ®Google Scholar
• SmithNLHeckbertSRLemaitreRNConjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal womenArterioscler Thromb Vasc Biol200626122807281216973976
   PubMed Web of Science ®Google Scholar
• SimonJABouchardCWaldbaumAUtianWZborowskiJSnabesMCLow dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trialObstet Gynecol2007109358859617329509
   PubMed Web of Science ®Google Scholar
• BachmannGASchaefersMUddinAUtianWHLowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trialObstet Gynecol2007110477177917906008
   PubMed Web of Science ®Google Scholar
• KicovicPMCortes-PrietoJMilojevićSHaspelsAAAljinovicAThe treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspectsMaturitas1980242752826785553
   PubMed Web of Science ®Google Scholar
• TakahashiKManabeAOkadaMKuriokaHKanasakiHMiyazakiKEfficacy and safety of oral estriol for managing postmenopausal symptomsMaturitas200034216917710714912
   PubMed Web of Science ®Google Scholar